Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with health-related quality of life 1 year after COVID-19: a cross-sectional study in Sweden.

Upsala journal of medical sciences·2026
Same author

A cross-border seroprevalence study on HBV, HCV, HDV and HIV in remote Amazonian communities on the border between French Guiana and Suriname.

PloS one·2026
Same author

Artificial Intelligence for Regulatory Evidence: A Systematic Document Analysis of European Medicines Agency Regulatory Advice and Public Reports.

Clinical pharmacology and therapeutics·2026
Same author

Impact of sensitivity difference between two widely used HDV RNA quantification assays on the management of HDV-infected patients treated with bulevirtide.

Journal of virological methods·2026
Same author

Diagnostic accuracy of Mucorales PCR testing in bronchoalveolar lavage fluid samples: a retrospective analysis of a prospectively collected cohort.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Update on the HDV seroprevalence and genotype distribution among patients positive for HBsAg referred to a National Reference Laboratory in Cameroon between January 2019 and December 2020.

IJID regions·2026

Related Experiment Video

Updated: Jul 17, 2025

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
11:00

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR

Published on: November 28, 2016

12.0K

HDV RNA assays: Performance characteristics, clinical utility, and challenges.

Heiner Wedemeyer1,2,3,4, Mitchell Leus5, Thomas R Battersby6

  • 1Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.

Hepatology (Baltimore, Md.)
|August 28, 2023
PubMed
Summary

Hepatitis D virus (HDV) RNA quantification is crucial for managing chronic hepatitis D, a severe liver disease. Developing reliable assays faces challenges due to viral diversity and lack of standardization, impacting patient monitoring and drug development.

More Related Videos

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.6K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.9K

Related Experiment Videos

Last Updated: Jul 17, 2025

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
11:00

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR

Published on: November 28, 2016

12.0K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.6K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.9K

Area of Science:

  • Hepatology
  • Virology
  • Molecular Diagnostics

Background:

  • Hepatitis D (coinfection with HBV and HDV) is the most severe form of chronic viral hepatitis.
  • It frequently leads to liver decompensation and hepatocellular carcinoma (HCC).
  • Current treatment options, like pegylated interferon alpha, have limited efficacy, but new therapies are emerging.

Purpose of the Study:

  • To review the challenges in developing reliable Hepatitis D virus RNA (HDV RNA) quantification assays.
  • To discuss the clinical importance of accurate HDV RNA monitoring for drug development and patient management.
  • To summarize the technical features and performance of existing HDV RNA assays.

Main Methods:

  • Review of existing literature on HDV RNA assay development and performance.
  • Analysis of factors contributing to assay variability, including viral heterogeneity and lack of standardization.
  • Discussion of the role of a World Health Organization (WHO) standard for HDV RNA.

Main Results:

  • Developing robust, pan-genotype HDV RNA assays is challenging due to viral diversity, rapid evolution, and RNA structure.
  • Variability in RNA extraction, assay design, and lack of automation contribute to inconsistent assay performance.
  • A WHO standard has aided in assay validation and inter-laboratory comparisons.

Conclusions:

  • Accurate and standardized HDV RNA quantification is essential for effective patient monitoring and the development of new hepatitis D treatments.
  • Addressing assay variability and improving standardization are critical for clinical decision-making.
  • Further research and development are needed for reliable, universally applicable HDV RNA assays.